-
EP4210710
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP4210710
| EP4210710 - NOVEL TREATMENT REGIMEN FOR THE TREATMENT OF AUTOIMMUNE DISORDERS [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 16.06.2023 Database last updated on 02.11.2024 | |
| Former | The international publication has been made Status updated on 23.03.2022 | ||
| Former | unknown Status updated on 22.10.2021 | Most recent event Tooltip | 12.07.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Merck Patent GmbH Frankfurter Strasse 250 64293 Darmstadt / DE | [2023/29] | Inventor(s) | 01 /
BOSCHERT, Ursula 1262 EYSINS / CH | 02 /
WIEDERMAN, Urs 80539 MUENCHEN / DE | [2023/29] | Representative(s) | Merck Patent Association Merck Patent GmbH 64271 Darmstadt / DE | [N/P] | Application number, filing date | 21786771.2 | 10.09.2021 | [2023/29] | WO2021EP74928 | Priority number, date | US202062706795P | 10.09.2020 Original published format: US 202062706795 P | US202062706819P | 11.09.2020 Original published format: US 202062706819 P | US202063198971P | 25.11.2020 Original published format: US 202063198971 P | US202063199265P | 16.12.2020 Original published format: US 202063199265 P | US202163149196P | 12.02.2021 Original published format: US 202163149196 P | US202163175318P | 15.04.2021 Original published format: US 202163175318 P | [2023/29] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022053608 | Date: | 17.03.2022 | Language: | EN | [2022/11] | Type: | A1 Application with search report | No.: | EP4210710 | Date: | 19.07.2023 | Language: | EN | The application published by WIPO in one of the EPO official languages on 17.03.2022 takes the place of the publication of the European patent application. | [2023/29] | Search report(s) | International search report - published on: | EP | 17.03.2022 | Classification | IPC: | A61K31/7076, A61P37/00 | [2023/29] | CPC: |
A61P37/00 (EP,IL,KR);
A61K31/7076 (EP,IL,KR,US);
A61K39/25 (US);
A61K39/215 (US);
A61P31/22 (US);
A61P37/04 (US);
A61K2039/5252 (US);
A61K2039/53 (US);
A61K2039/545 (US);
A61K2039/55 (US);
C12N2710/16734 (US);
C12N2770/20033 (US);
Y02A50/30 (EP,IL)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/29] | Title | German: | NEUARTIGES BEHANDLUNGSSCHEMA ZUR BEHANDLUNG VON AUTOIMMUNERKRANKUNGEN | [2023/29] | English: | NOVEL TREATMENT REGIMEN FOR THE TREATMENT OF AUTOIMMUNE DISORDERS | [2023/29] | French: | NOUVEAU RÉGIME DE TRAITEMENT POUR LE TRAITEMENT DE TROUBLES AUTO-IMMUNS | [2023/29] | Entry into regional phase | 31.03.2023 | National basic fee paid | 31.03.2023 | Designation fee(s) paid | 31.03.2023 | Examination fee paid | Examination procedure | 31.03.2023 | Amendment by applicant (claims and/or description) | 31.03.2023 | Examination requested [2023/29] | 31.03.2023 | Date on which the examining division has become responsible | Fees paid | Renewal fee | 24.08.2023 | Renewal fee patent year 03 | 11.07.2024 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]US2006121052 (SOTELO-MORALES JULIO E [MX], et al); | [A]WO2019101960 (MERCK PATENT GMBH [DE]); | by applicant | EP0173059 | US5208327 | US5506214 | WO9619230 | WO9619229 | WO0064918 | US6194395 | WO2004028462 | WO2004087100 | WO2004087101 |